Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities FATE - Fate Therapeutics, Inc.
113 M
LAST VALUE
53.22%
2 YEAR CAGR
200.57%
5 YEAR CAGR
85.23%
10 YEAR CAGR